Skip Navigation Links.
Collapse Translocation
Skip Navigation LinksHome | Drug Discovery | Lead Selection | Kinase Testing Services | Cell-Based | Translocation | NF-κB SignaLocator
NF-κB SignaLocator (p65 NF-kB Cytoplasm to Nucleus Translocation Assay)

Automated Image Analysis

Nuclei are shown in red. p65 NF-κB is in green. Image masks are labeled in blue for nuclei and red for cytoplasm.

Inhibitor EMD
Bioscience
Cat.#
NF-κB
Assay
EC50
NF-κB Activation Inhibitor 481406 >100µM
NF-κB Activation Inhibitor II, JSH-23 481408 >100µM
NF-κB Activation Inhibitor III 481411 >100µM
IKK Inhibitor II, Wedelolactone 401474 >100µM
IKK Inhibitor III, BMS-345541 401480 3.9µM
SN50 481480 >30µM
Bay 11-7082 196870 22.2µM

MDS Pharma Services Advantage
  • Cell-based assay for more physiologically relevant output
  • Minimum compound consumption for 384 well plate format
  • Automated, robust and cost-effective
  • Accelerated throughput screening (900 compounds per week)
  • Objective, consistent and fast
Service Features
  • Compound testing in HeLa or HUVEC cell lines
  • Direct visualization and automated quantitation of NF-κB
  • Minimum compound requirements due to 384 well plate formats and non-contact acoustic energy based compound addition
  • A reference compound included as a control on each plate
  • 4 week turnaround time

Contact Us for additional HCA based assay information.